TriSalus Life Valuation
| TLSI Stock | 5.07 0.17 3.47% |
At this time, the company appears to be overvalued. TriSalus Life Sciences has a current Real Value of USD4.36 per share. The regular price of the company is USD5.07. Our model measures the value of TriSalus Life Sciences from inspecting the company fundamentals such as Return On Equity of -4.96, shares outstanding of 37.98 M, and Operating Margin of (0.80) % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that TriSalus Life's price fluctuation is moderately volatile at this time. Calculation of the real value of TriSalus Life Sciences is based on 3 months time horizon. Increasing TriSalus Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TriSalus Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TriSalus Stock. However, TriSalus Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.07 | Real 4.36 | Hype 5.07 | Naive 5.11 |
The intrinsic value of TriSalus Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence TriSalus Life's stock price.
Estimating the potential upside or downside of TriSalus Life Sciences helps investors to forecast how TriSalus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TriSalus Life more accurately as focusing exclusively on TriSalus Life's fundamentals will not take into account other important factors: TriSalus Life Total Value Analysis
TriSalus Life Sciences is at this time projected to have valuation of 212.65 M with market capitalization of 192.54 M, debt of 23.63 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the TriSalus Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
212.65 M | 192.54 M | 23.63 M |
TriSalus Life Investor Information
About 50.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.1. TriSalus Life Sciences had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from TriSalus Life's historical financial statements, TriSalus Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.TriSalus Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. TriSalus Life has an asset utilization ratio of 122.78 percent. This signifies that the Company is making USD1.23 for each dollar of assets. An increasing asset utilization means that TriSalus Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.TriSalus Life Ownership Allocation
TriSalus Life Sciences shows a total of 37.98 Million outstanding shares. TriSalus Life Sciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.TriSalus Life Profitability Analysis
The company reported the previous year's revenue of 29.43 M. Net Loss for the year was (30.05 M) with profit before overhead, payroll, taxes, and interest of 27.51 M.About TriSalus Life Valuation
An absolute valuation paradigm, as applied to TriSalus Stock, attempts to find the value of TriSalus Life Sciences based on its fundamental and basic technical indicators. By analyzing TriSalus Life's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of TriSalus Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of TriSalus Life. We calculate exposure to TriSalus Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TriSalus Life's related companies.TriSalus Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 26.5 M |
Complementary Tools for TriSalus Stock analysis
When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |